SEATTLE (AP) — SEATTLE (AP) — Sana Biotechnology Inc. (SANA) on Friday reported a loss of $59.9 million in its third quarter.
On a per-share basis, the Seattle-based company said it had a loss of 25 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SANA at https://www.zacks.com/ap/SANA
